SL Science Holding Limited (SLBT) fair value analysis
Nasdaq · Updated 2026-10-19
SLBT price how computed
Valuation status
No fair-value estimate yetSLBT has no usable analyst consensus for next fiscal year's earnings, or too few reported quarters for our trailing P/E history.
Forward Fair Value needs both, so TickrTrends publishes no verdict for SLBT yet. We re-check every week; the price, fundamentals, technicals and earnings data below are unaffected.
- Last price
- $1.53
- Sector
- Healthcare
- 12-month range
- $1.53–$4.45
- Market cap
- $858M
- From 52-week high
- -65.6%
- Shares outstanding
- 561M
Last price is the 2026-10-16 close; the chart runs through 2026-10-16.
SL Science Holding Limited is a healthcare company listed on Nasdaq under the ticker SLBT that focuses on developing and commercializing pharmaceutical and biotechnology products. The company operates primarily in China and serves markets across Asia and other regions.
Fundamentals (3 quarters) how computed
- Market cap
- $858M
- Shares outstanding
- 561M
Derived indicators how computed
- 50/200-day trend
- Downtrend
- 52-week position
- The bottom quarter of its range
What our data shows for SLBT
- Shares are trading in the lower third of their 12-month price range of $1.53–$4.45.
What subscribers see
- Every published Forward Fair Value with its exact discount or premium
- The normalized P/E and quarter count behind each estimate
- Screeners and rankings across the full S&P 500 and Nasdaq universes
- SLBT's own verdict the week it qualifies, published automatically
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
What people are saying
Follow the SLBT conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-05 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-28 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is SLBT stock undervalued?
TickrTrends has no fair-value estimate for SLBT yet: there is no usable analyst consensus for next fiscal year's earnings, or too few reported quarters for a trailing P/E history. It is re-checked every week.
What is SLBT's TickrTrends verdict?
SLBT is currently marked 'No fair-value estimate yet' - a verdict publishes automatically once a forward earnings consensus and enough reported quarters are available.
Is SLBT overbought or oversold?
TickrTrends does not currently publish an RSI signal for SLBT.